Adjuvant and neoadjuvant therapy of rectal cancer: Actual data;Adjuvante und neoadjuvante therapie des rektumkarzinoms: Aktueller stand

Strahlentherapie und Onkologie

Volumn 174, Issue 10, 1998, Pages 497-503

  Rödel, Claus ^a,b   Hohenberger, Werner ^a   Sauer, Rolf ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Adjuvant and Neoadjuvant Therapy; Radiochemotherapy; Rectal Cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; SEMUSTINE;

CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GERMANY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; REVIEW;

EID: 0031756684     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038981     Document Type: Review

References (41)

1. Arnaud JP, Nordlinger B, Bosset JF, et al. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer. Br J Surg 1997;84:352-7.
2. Blackledge G. New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed (Tomudex). Br J Cancer (Scotland) 1998;77:29-37.
3. Boulis-Wassif S, Gerard A, Loygue L, et al. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil followed by radical surgery. Cancer 1984;53:1811-8.
4. Casillas S, Pelley RJ, Milsom JW. Adjuvant therapy for colorectal cancer: present and future perspectives. Dis Colon Rectum 1997;40:977-92.
5. Cedermark B. The Stockholm II trial on preoperative short term radiotherapy in operable rectal cancer: a prospective randomized trial. Proc Am Soc Clin Oncol 1994;13:198.abstract.
6. Cedermark B, Johansson H, Rutqvist LE, et al. The Stockholm I trial of preoperative short term radiotherapy in operable rectal cancer: a prospective randomized trial. Cancer 1995;75:2269-75.
7. Chari RS, Tyler DS, Anscher MS, et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:779-87.
8. Dahlberg M, Glimelius B, Graf W, et al. Preoperative irradiation affects functional results after surgery for rectal cancer. Dis Colon Rectum 1998;41:543-51.
9. Fietkau R, Dunst J, Klautke G, et al. Kombinierte Immuntherapie mit dem monoklonalen Antikörper 17-1A und Radiochemotherapie bei Patienten mit fortgeschrittenem Rektumkarzinom. Strahlenther Onkol 1997;173:549.abstract.
10. Freedmann GM, Coia L. Adjuvant and neoadjuvant treatment of rectal cancer. Semin Oncol 1995;22:611-24.
11. Gall FP, Hermanek P. Wandel und derzeitiger Stand der chirurgischen Behandlung des colorektalen Carcinoms. Erfahrungsbericht der Chirurgischen Universitätsklinik Erlangen. Chirurg 1992;63:227-34.
12. Gastrointestinal Tumor Study Group (GITSG): Survival after postoperative combination treatment of rectal cancer. New Engl J Med 1986;315:1294-5.
13. Gastrointestinal Tumor Study Group (GITSG): Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992;7:549-57.
14. Gerard A, Berrod JL, Pene F, et al. Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Cancer 1985;55:2373-9.
15. Hermanek P, Wiebelt H, Staimmer D, et al. and the German Study Group Colo-Rectal Carcinoma (SGCRC): Prognostic factors of rectum carcinoma. Experience of the German Multicenter Study SGCRC Tumori 1995;81:60-4.
16. Hohenberger W, Günther K, Fietkau R. Is radiochemotherapy necessary in the treatment of rectal cancer? Eur J Cancer 1998;34:441-6.
17. Hohenberger W, Hermanek P. Weite des aboralen Sicherheitsabstandes bei anteriorer Rektumresektion. In: Gall FP, Zirngibl H, Hermanek P, Hrsg. Das kolorektale Karzinom. Kontroverse Fragen, neue Ergebnisse. München: Zuckschwerdt, 1989:161-74.
18. Holm T, Rutquist LE, Johansson H, et al. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg 1996;83:964-8.
19. Hyams DM, Mamounas EP, Petrelli N, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of NSABP R-03. Dis Colon Rectum 1997;40:131-9.
20. Köckerling F, Reymond MA, Altendorf-Hofmann A, et al. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998;16:324-9.
21. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. New Engl J Med 1991;324:709-15.
22. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
23. Marsh RW, Chu NM, Vauthey JN, et al. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 1996;78:217-25.
24. Mendenhall WM, Bland KI, Copeland EM, et al. Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer. Ann Surg 1992;215:696-706.
25. Minsky BD. Adjuvant therapy for rectal cancer - a good first step. New Engl J Med 1997;14:1016-7.
26. Minsky BD, Cohen AM, Enker WE, et al. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553-9.
27. Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992;10:79-84.
28. Myerson RJ, Michalski JM, King ML, et al. Adjuvant radiation for rectal carcinoma: predictors of outcome. Int J Radiat Oncol Biol Phys 1995;32:41-50.
29. National Cancer Institute. Clinical announcement. 14. März 1991.
30. NIH Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. J Am Med Ass 1990;264:1444.
31. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. New Engl J Med 1994;331:502-7.
32. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Ann Surg 1990;211:187-95.
33. Pichlmaier H, Hossfeld DK, Sauer R. Konsensus der CAO, AIO und ARO zur adjuvanten Therapie bei Colon- und Rectumcarcinom vom 11. März 1994. Chirurg 1994;65:411-2.
34. Rich TA, Skipper JM, Jaffer JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-9.
35. Rödel C, Schick CH, Raab R, et al. Prospectively randomized trial of preoperative versus postoperative radiochemotherapy for advanced rectal cancer - first results regarding surgical morbidity and toxicity of (neo-)adjuvant treatment. Eur J Surg Oncol 1998;24:208.abstract.
36. Sauer R, Heuser A. Topoisomerase-I-Inhibitor mit potentiell strahlensensibilisierender Wirkung. Strahlenther Onkol 1997;173:125-30.
37. Sauer R, Dunst J. Adjuvante und neoadjuvante Radiochemotherapie des Rektumkarzinoms. Onkologe 1995;1:36-42.
38. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. New Engl J Med 1997;336:980-7.
39. Tepper JE, O'Connell MJ, Petron GR, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 1997;15:2030-9.
40. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg 1997;84:1130-5.
41. Wiggers T. Total mesorectal excision: a new standard for the surgical treatment of rectal carcinoma (letter). Ned Tijdschr Geneeskd 1996;140:17.